| Literature DB >> 32125287 |
Masato Tanuma1, Atsushi Kasai1, Kazuki Bando2,3, Naoyuki Kotoku4, Kazuo Harada5,6, Masafumi Minoshima7, Kosuke Higashino1, Atsushi Kimishima8, Masayoshi Arai8, Yukio Ago1,9, Kaoru Seiriki1,10, Kazuya Kikuchi7,11, Satoshi Kawata2,3, Katsumasa Fujita2,12,13, Hitoshi Hashimoto1,12,14,15,16.
Abstract
Detailed spatial information of low-molecular weight compound distribution, especially in the brain, is crucial to understanding their mechanism of actions. Imaging techniques that can directly visualize drugs in the brain at a high resolution will complement existing tools for drug distribution analysis. Here, we performed surface-enhanced Raman scattering (SERS) imaging using a bioorthogonal alkyne tag to visualize drugs directly in situ at a high resolution. Focusing on the selective serotonin reuptake inhibitor S-citalopram (S-Cit), which possesses a nitrile group, we substituted an alkynyl group into its structure and synthesized alkynylated S-Cit (Alk-S-Cit). The brain transitivity and the serotonin reuptake inhibition of Alk-S-Cit were not significantly different as compared with S-Cit. Alk-S-Cit was visualized in the coronal mouse brain section using SERS imaging with silver nanoparticles. Furthermore, SERS imaging combined with fluorescence microscopy allowed Alk-S-Cit to be visualized in the adjacent neuronal membranes, as well as in the brain vessel and parenchyma. Therefore, our multimodal imaging technique is an effective method for detecting low-molecular weight compounds in their original tissue environment and can potentially offer additional information regarding the precise spatial distribution of such drugs.Entities:
Keywords: Neuroimaging; Neuroscience; Pharmacology
Mesh:
Substances:
Year: 2020 PMID: 32125287 PMCID: PMC7213792 DOI: 10.1172/jci.insight.133348
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708